Weber F H, Sears R J, Kendall B, Pruett T L, Shaffer H A, Yeaton P
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville 22906-0013, USA.
Dig Dis Sci. 1997 Jun;42(6):1168-75. doi: 10.1023/a:1018885519918.
The effect of octreotide on sphincter of Oddi motility was investigated in six liver transplant patients, employing percutaneous (through the T-tube tract) manometry. Continuous and simultaneous sphincter of Oddi and duodenal motor activities were recorded before and for 60 min after the administration of octreotide (100 micrograms subcutaneously) and after the injection of cholecystokinin (0.02 microgram/kg intravenously). With octreotide, contraction frequency and basal pressure significantly increased (P < 0.05). This effect lasted more than 60 min, long after octreotide-induced duodenal migrating motor complex phase III activity had ceased. Sphincter of Oddi contraction amplitude and duration were unaffected by octreotide. Subsequent cholecystokinin administration transiently reduced sphincter of Oddi basal pressure and contraction frequency. We conclude that octreotide significantly increases sphincter of Oddi basal pressure and contraction frequency. This effect is distinct from octreotide induction of migrating motor complex phase III activity, persists for a prolonged period, and is inhibited by cholecystokinin.
采用经皮(通过T管通道)测压法,在6例肝移植患者中研究了奥曲肽对Oddi括约肌运动的影响。在皮下注射奥曲肽(100微克)后以及静脉注射胆囊收缩素(0.02微克/千克)后,分别在给药前及给药后60分钟连续同步记录Oddi括约肌和十二指肠的运动活动。使用奥曲肽后,收缩频率和基础压力显著增加(P<0.05)。这种作用持续超过60分钟,远在奥曲肽诱导的十二指肠移行性运动复合波Ⅲ期活动停止之后。奥曲肽对Oddi括约肌的收缩幅度和持续时间无影响。随后给予胆囊收缩素可使Oddi括约肌基础压力和收缩频率短暂降低。我们得出结论,奥曲肽可显著增加Oddi括约肌的基础压力和收缩频率。这种作用不同于奥曲肽诱导的移行性运动复合波Ⅲ期活动,持续时间较长,且受胆囊收缩素抑制。